Loading...

La Cava, Antonio

Title(s)Professor-in-Residence, Medicine
SchoolRheumatology
Phone3102674975
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Antibody-mediated suppression of autoimmunity in humanized mice
    NIH/NICHD R21HD097531Mar 17, 2019 - Feb 28, 2021
    Role: Principal Investigator
    Leptin and mTOR: metabolic partners in autoimmunity
    NIH/NIAID R21AI109677Jul 1, 2015 - Jun 30, 2017
    Role: Principal Investigator
    Sexual Dimorphism and Dysregulated Immune Responses in SLE: The Role of Leptin
    NIH/NIAID R21AI095921Aug 18, 2011 - Jul 31, 2013
    Role: Principal Investigator
    Role of Leptin in Systemic Lupus Erythematosus
    NIH/NIAMS R01AR053239Aug 1, 2006 - Jun 30, 2012
    Role: Principal Investigator
    Leptin-based intervention in systemic autoimmunity
    NIH/NIAID R21AI063515Apr 1, 2005 - Mar 31, 2008
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. La Cava A. The Influence of Diet and Obesity on Gene Expression in SLE. Genes (Basel). 2019 05 27; 10(5). PMID: 31137916.
      View in: PubMed
    2. La Cava A. Tregs in SLE: an Update. Curr Rheumatol Rep. 2018 02 21; 20(2):6. PMID: 29464438.
      View in: PubMed
    3. La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017 10; 98:51-58. PMID: 27916613.
      View in: PubMed
    4. La Cava A. Targeting the BLyS-APRIL signaling pathway in SLE. Clin Immunol. 2013 Sep; 148(3):322-7. PMID: 23269199.
      View in: PubMed
    5. La Cava A. Proinflammatory activities of leptin in non-autoimmune conditions. Inflamm Allergy Drug Targets. 2012 Aug 01; 11(4):298-302. PMID: 22458591.
      View in: PubMed
    6. La Cava A. Adiponectin: a relevant player in obesity-related colorectal cancer? Gut. 2013 Apr; 62(4):483-4. PMID: 22851665.
      View in: PubMed
    7. La Cava A. Targeting B cells with biologics in systemic lupus erythematosus. Expert Opin Biol Ther. 2010 Nov; 10(11):1555-61. PMID: 20919800.
      View in: PubMed
    8. La Cava A. Modulation of autoimmunity with artificial peptides. Autoimmun Rev. 2010 Nov; 10(1):18-21. PMID: 20807590.
      View in: PubMed
    9. La Cava A. Anticytokine therapies in systemic lupus erythematosus. Immunotherapy. 2010 Jul; 2(4):575-82. PMID: 20636010.
      View in: PubMed
    10. La Cava A. The busy life of regulatory T cells in systemic lupus erythematosus. Discov Med. 2009 Jun; 8(40):13-7. PMID: 19772836.
      View in: PubMed
    11. La Cava A. Lupus and T cells. Lupus. 2009 Mar; 18(3):196-201. PMID: 19213856.
      View in: PubMed
    12. La Cava A. Natural Tregs and autoimmunity. Front Biosci (Landmark Ed). 2009 Jan 01; 14:333-43. PMID: 19273070.
      View in: PubMed
    13. La Cava A. Immunotherapy with peptides in systemic lupus erythematosus. Curr Med Chem. 2009; 16(12):1482-8. PMID: 19355901.
      View in: PubMed
    14. La Cava A. Tregs are regulated by cytokines: implications for autoimmunity. Autoimmun Rev. 2008 Oct; 8(1):83-7. PMID: 18771756.
      View in: PubMed
    15. La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus. 2008 May; 17(5):421-5. PMID: 18490420.
      View in: PubMed
    16. La Cava A, Van Kaer L. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol. 2006 Jul; 27(7):322-7. PMID: 16735139.
      View in: PubMed
    17. La Cava A, Shi FD. Natural and adaptive immune cell-based therapies in autoimmunity. Curr Med Chem. 2006; 13(13):1557-66. PMID: 16787203.
      View in: PubMed
    18. La Cava A, Fang CJ, Singh RP, Ebling F, Hahn BH. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev. 2005 Nov; 4(8):515-9. PMID: 16214088.
      View in: PubMed
    19. La Cava A, Ebling FM, Hahn BH. Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol. 2004 Sep 01; 173(5):3542-8. PMID: 15322219.
      View in: PubMed
    20. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol. 2004 May; 4(5):371-9. PMID: 15122202.
      View in: PubMed
    21. La Cava A, Matarese G, Ebling FM, Hahn BH. Leptin-based immune intervention: current status and future directions. Curr Opin Investig Drugs. 2003 Nov; 4(11):1327-32. PMID: 14758772.
      View in: PubMed